• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血浆前载脂蛋白A-I:分离及氨基末端序列

Human plasma proapoA-I: isolation and amino-terminal sequence.

作者信息

Brewer H B, Fairwell T, Kay L, Meng M, Ronan R, Law S, Light J A

出版信息

Biochem Biophys Res Commun. 1983 Jun 15;113(2):626-32. doi: 10.1016/0006-291x(83)91772-2.

DOI:10.1016/0006-291x(83)91772-2
PMID:6409108
Abstract

Human apoA-I is synthesized as preproapoA-I, a 267 amino acid precursor apolipoprotein. PreproapoA-I initially undergoes intracellular co-translational proteolytic cleavage into proapoA-I. ProapoA-I is secreted from the cell and was isolated from thoracic duct lymph in the apoA-I1 isoform position. The amino-terminal sequence of proapoA-I isolated from human lymph revealed the presence of 6 additional amino acids, Arg-His-Phe-Trp-Gln-Gln, on the amino-terminal end of apoA-I consistent with the proapoA-I sequence determined by nucleic acid sequence analysis of cloned apoA-I. Our results indicate that proapoA-I is present in human plasma, and undergoes post-translational proteolytic cleavage to mature plasma apoA-I.

摘要

人载脂蛋白A-I最初作为前体载脂蛋白A-I合成,它是一种含有267个氨基酸的前体载脂蛋白。前体载脂蛋白A-I最初在细胞内经历共翻译蛋白水解切割,形成载脂蛋白A-I原。载脂蛋白A-I原从细胞中分泌出来,并在载脂蛋白A-I1异构体位置从胸导管淋巴中分离出来。从人淋巴中分离出的载脂蛋白A-I原的氨基末端序列显示,在载脂蛋白A-I的氨基末端存在另外6个氨基酸,即精氨酸-组氨酸-苯丙氨酸-色氨酸-谷氨酰胺-谷氨酰胺,这与通过克隆的载脂蛋白A-I的核酸序列分析确定的载脂蛋白A-I原序列一致。我们的结果表明,载脂蛋白A-I原存在于人体血浆中,并经历翻译后蛋白水解切割,形成成熟的血浆载脂蛋白A-I。

相似文献

1
Human plasma proapoA-I: isolation and amino-terminal sequence.人血浆前载脂蛋白A-I:分离及氨基末端序列
Biochem Biophys Res Commun. 1983 Jun 15;113(2):626-32. doi: 10.1016/0006-291x(83)91772-2.
2
Human proapoA-ITangier: isolation of proapoA-ITangier and amino acid sequence of the propeptide.人源前载脂蛋白A-I丹吉尔型:前载脂蛋白A-I丹吉尔型的分离及前肽的氨基酸序列
Biochem Biophys Res Commun. 1983 Jun 29;113(3):934-40. doi: 10.1016/0006-291x(83)91088-4.
3
Identification of proapoa-I in rat lymph and plasma: metabolic conversion to "mature" apoA-I.大鼠淋巴液和血浆中前载脂蛋白A-I的鉴定:向“成熟”载脂蛋白A-I的代谢转化。
Biochem Biophys Res Commun. 1983 Oct 31;116(2):704-11. doi: 10.1016/0006-291x(83)90582-x.
4
cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I.人载脂蛋白A-I的cDNA克隆:前体载脂蛋白A-I的氨基酸序列
Biochem Biophys Res Commun. 1983 Apr 15;112(1):257-64. doi: 10.1016/0006-291x(83)91824-7.
5
Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I.人载脂蛋白A-I同工蛋白代谢:前载脂蛋白A-I转化为成熟载脂蛋白A-I。
J Lipid Res. 1985 Feb;26(2):185-93.
6
Proapolipoprotein A-I conversion kinetics in vivo in human and in rat.人及大鼠体内前载脂蛋白A-I的转化动力学
Proc Natl Acad Sci U S A. 1985 Feb;82(3):874-8. doi: 10.1073/pnas.82.3.874.
7
Enzyme-linked immunosorbent assay for human proapolipoprotein A-I using specific antibodies against synthetic peptide.使用针对合成肽的特异性抗体的人载脂蛋白A-I前体的酶联免疫吸附测定。
J Lipid Res. 1988 Jan;29(1):77-84.
8
In vivo metabolism of proapolipoprotein A-I in Tangier disease.丹吉尔病中载脂蛋白A-I前体的体内代谢
J Clin Invest. 1987 Dec;80(6):1742-7. doi: 10.1172/JCI113266.
9
High yield overexpression and characterization of human recombinant proapolipoprotein A-I.人重组载脂蛋白A-I的高效过表达及特性分析
J Lipid Res. 1996 Jul;37(7):1519-28.
10
Human proapolipoprotein A-I: development of an antibody to the propeptide as a probe of apolipoprotein A-I biosynthesis and processing.人载脂蛋白A-I前体:抗前肽抗体的研制及其作为载脂蛋白A-I生物合成与加工研究探针的应用
Biochem Biophys Res Commun. 1987 Nov 30;149(1):289-96. doi: 10.1016/0006-291x(87)91637-8.

引用本文的文献

1
Biomarkers of Major Depressive Disorder: Knowing is Half the Battle.重度抑郁症的生物标志物:知其然是成功的一半。
Clin Psychopharmacol Neurosci. 2021 Feb 28;19(1):12-25. doi: 10.9758/cpn.2021.19.1.12.
2
The Positive Side of the Alzheimer's Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1.阿尔茨海默病淀粉样交叉相互作用的积极面:Aβ 1-42 肽与 Tau、TTR、CysC 和 ApoA1 的情况。
Molecules. 2020 May 23;25(10):2439. doi: 10.3390/molecules25102439.
3
Parkinson's Disease: Biomarkers, Treatment, and Risk Factors.
帕金森病:生物标志物、治疗方法及风险因素
Front Neurosci. 2018 Aug 30;12:612. doi: 10.3389/fnins.2018.00612. eCollection 2018.
4
Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.载脂蛋白和α-突触核蛋白在帕金森病中的作用。
J Mol Neurosci. 2017 Aug;62(3-4):344-355. doi: 10.1007/s12031-017-0942-9. Epub 2017 Jul 10.
5
What does procollagen C-endopeptidase enhancer protein 2 have to do with HDL-cholesteryl ester uptake? Or how I learned to stop worrying and love reverse cholesterol transport?前胶原C端肽酶增强蛋白2与高密度脂蛋白胆固醇酯摄取有何关系?或者说我是如何学会不再担忧并爱上逆向胆固醇转运的?
Curr Opin Lipidol. 2015 Oct;26(5):420-5. doi: 10.1097/MOL.0000000000000211.
6
Potential biomarkers in psychiatry: focus on the cholesterol system.精神病学中的潜在生物标志物:关注胆固醇系统。
J Cell Mol Med. 2012 Jun;16(6):1184-95. doi: 10.1111/j.1582-4934.2012.01543.x.
7
Cubbing in proapolipoprotein maturation.载脂蛋白前体成熟过程中的“小窝”作用
J Lipid Res. 2011 Nov;52(11):1861-4. doi: 10.1194/jlr.R020149. Epub 2011 Sep 6.
8
Nucleotide sequence and the encoded amino acids of human apolipoprotein A-I mRNA.人载脂蛋白A-I mRNA的核苷酸序列及编码的氨基酸
Proc Natl Acad Sci U S A. 1984 Jan;81(1):66-70. doi: 10.1073/pnas.81.1.66.
9
In vivo metabolism of proapolipoprotein A-I in Tangier disease.丹吉尔病中载脂蛋白A-I前体的体内代谢
J Clin Invest. 1987 Dec;80(6):1742-7. doi: 10.1172/JCI113266.